Lin Patrick
SEC insider (Form 3/4/5 filer). CIK 0001799363. Chief Business - Strategy Off at Processa Pharmaceuticals, Inc. (PCSA). 17 reported Form 4/5 transactions since Sep 2024; latest on Jul 26, 2026. Located in VERO BEACH, FL.
Companies Lin Patrick has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Officer, Chief Business - Strategy Off
Lin Patrick
CIK: 0001799363
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Processa Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
8.5K shares- - Jun 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.1K shares at avg. $1.93$4K - Jun 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.8K shares at avg. $2.22$4K - May 29, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.6K shares at avg. $2.57$4K - May 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.4K shares at avg. $2.97$4K - Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.5K shares at avg. $2.69$4K - Apr 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.4K shares at avg. $2.97$4K - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.6K shares at avg. $2.54$4K - Jan 1, 2026PCSA
Processa Pharmaceuticals, Inc.
ExerciseDirect193 shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
204K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 8,450 | - | - | Direct |
| Jun 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,106 | $1.93 | $4,065 | Direct |
| Jun 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,831 | $2.22 | $4,065 | Direct |
| May 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,582 | $2.57 | $4,066 | Direct |
| May 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,369 | $2.97 | $4,066 | Direct |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,511 | $2.69 | $4,065 | Direct |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,369 | $2.97 | $4,066 | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,603 | $2.54 | $4,064 | Direct |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | Exercise | 193 | - | $0 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 204,000 | - | - | Direct |
1-10 of 17 transactions